LadRx Corp. (LADX)
0.011
0.00 (0.00%)
USD |
OTCM |
Oct 29, 16:00
LadRx EPS Diluted (Quarterly)
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | -1.453 |
| December 31, 2024 | 0.6688 |
| September 30, 2024 | -1.665 |
| June 30, 2024 | -2.591 |
| March 31, 2024 | 0.3772 |
| December 31, 2023 | -1.733 |
| September 30, 2023 | -1.648 |
| June 30, 2023 | 6.448 |
| March 31, 2023 | -248.10 |
| December 31, 2022 | -224.90 |
| September 30, 2022 | -277.70 |
| June 30, 2022 | -224.80 |
| March 31, 2022 | -385.00 |
| December 31, 2021 | -2371.80 |
| September 30, 2021 | -440.60 |
| June 30, 2021 | -321.70 |
| March 31, 2021 | -350.70 |
| December 31, 2020 | -387.00 |
| September 30, 2020 | -788.30 |
| June 30, 2020 | -400.30 |
| March 31, 2020 | -350.00 |
| December 31, 2019 | -889.10 |
| September 30, 2019 | -442.60 |
| June 30, 2019 | -383.30 |
| March 31, 2019 | -428.90 |
| Date | Value |
|---|---|
| December 31, 2018 | -694.90 |
| September 30, 2018 | -997.50 |
| June 30, 2018 | -993.80 |
| March 31, 2018 | -1487.90 |
| December 31, 2017 | -1590.60 |
| September 30, 2017 | -1900.20 |
| June 30, 2017 | -6000.00 |
| March 31, 2017 | -6000.00 |
| December 31, 2016 | -4800.00 |
| September 30, 2016 | -7800.00 |
| June 30, 2016 | -16200.00 |
| March 31, 2016 | -11400.00 |
| December 31, 2015 | -20400.00 |
| September 30, 2015 | -6600.00 |
| June 30, 2015 | -12600.00 |
| March 31, 2015 | -18600.00 |
| December 31, 2014 | -14400.00 |
| September 30, 2014 | -6000.00 |
| June 30, 2014 | -16800.00 |
| March 31, 2014 | 4800.00 |
| December 31, 2013 | -40800.00 |
| September 30, 2013 | -19800.00 |
| June 30, 2013 | -6600.00 |
| March 31, 2013 | -13800.00 |
| December 31, 2012 | 8400.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |